182 related articles for article (PubMed ID: 11279193)
1. Molecular basis for severe epimerase deficiency galactosemia. X-ray structure of the human V94m-substituted UDP-galactose 4-epimerase.
Thoden JB; Wohlers TM; Fridovich-Keil JL; Holden HM
J Biol Chem; 2001 Jun; 276(23):20617-23. PubMed ID: 11279193
[TBL] [Abstract][Full Text] [Related]
2. Comparison of dynamics of wildtype and V94M human UDP-galactose 4-epimerase-A computational perspective on severe epimerase-deficiency galactosemia.
Timson DJ; Lindert S
Gene; 2013 Sep; 526(2):318-24. PubMed ID: 23732289
[TBL] [Abstract][Full Text] [Related]
3. Studies of the V94M-substituted human UDPgalactose-4-epimerase enzyme associated with generalized epimerase-deficiency galactosaemia.
Wohlers TM; Fridovich-Keil JL
J Inherit Metab Dis; 2000 Nov; 23(7):713-29. PubMed ID: 11117433
[TBL] [Abstract][Full Text] [Related]
4. Crystallographic evidence for Tyr 157 functioning as the active site base in human UDP-galactose 4-epimerase.
Thoden JB; Wohlers TM; Fridovich-Keil JL; Holden HM
Biochemistry; 2000 May; 39(19):5691-701. PubMed ID: 10801319
[TBL] [Abstract][Full Text] [Related]
5. Functional analysis of disease-causing mutations in human UDP-galactose 4-epimerase.
Timson DJ
FEBS J; 2005 Dec; 272(23):6170-7. PubMed ID: 16302980
[TBL] [Abstract][Full Text] [Related]
6. Identification and characterization of a mutation, in the human UDP-galactose-4-epimerase gene, associated with generalized epimerase-deficiency galactosemia.
Wohlers TM; Christacos NC; Harreman MT; Fridovich-Keil JL
Am J Hum Genet; 1999 Feb; 64(2):462-70. PubMed ID: 9973283
[TBL] [Abstract][Full Text] [Related]
7. The molecular basis of galactosemia - Past, present and future.
Timson DJ
Gene; 2016 Sep; 589(2):133-41. PubMed ID: 26143117
[TBL] [Abstract][Full Text] [Related]
8. Human UDP-galactose 4-epimerase. Accommodation of UDP-N-acetylglucosamine within the active site.
Thoden JB; Wohlers TM; Fridovich-Keil JL; Holden HM
J Biol Chem; 2001 May; 276(18):15131-6. PubMed ID: 11279032
[TBL] [Abstract][Full Text] [Related]
9. Epimerase-deficiency galactosemia is not a binary condition.
Openo KK; Schulz JM; Vargas CA; Orton CS; Epstein MP; Schnur RE; Scaglia F; Berry GT; Gottesman GS; Ficicioglu C; Slonim AE; Schroer RJ; Yu C; Rangel VE; Keenan J; Lamance K; Fridovich-Keil JL
Am J Hum Genet; 2006 Jan; 78(1):89-102. PubMed ID: 16385452
[TBL] [Abstract][Full Text] [Related]
10. UDP-hexose 4-epimerases: a view on structure, mechanism and substrate specificity.
Beerens K; Soetaert W; Desmet T
Carbohydr Res; 2015 Sep; 414():8-14. PubMed ID: 26162744
[TBL] [Abstract][Full Text] [Related]
11. Structural analysis of the Y299C mutant of Escherichia coli UDP-galactose 4-epimerase. Teaching an old dog new tricks.
Thoden JB; Henderson JM; Fridovich-Keil JL; Holden HM
J Biol Chem; 2002 Jul; 277(30):27528-34. PubMed ID: 12019271
[TBL] [Abstract][Full Text] [Related]
12. Human UDP-galactose 4' epimerase (GALE) gene and identification of five missense mutations in patients with epimerase-deficiency galactosemia.
Maceratesi P; Daude N; Dallapiccola B; Novelli G; Allen R; Okano Y; Reichardt J
Mol Genet Metab; 1998 Jan; 63(1):26-30. PubMed ID: 9538513
[TBL] [Abstract][Full Text] [Related]
13. Mediators of galactose sensitivity in UDP-galactose 4'-epimerase-impaired mammalian cells.
Schulz JM; Ross KL; Malmstrom K; Krieger M; Fridovich-Keil JL
J Biol Chem; 2005 Apr; 280(14):13493-502. PubMed ID: 15701638
[TBL] [Abstract][Full Text] [Related]
14. Molecular structures of the S124A, S124T, and S124V site-directed mutants of UDP-galactose 4-epimerase from Escherichia coli.
Thoden JB; Gulick AM; Holden HM
Biochemistry; 1997 Sep; 36(35):10685-95. PubMed ID: 9271499
[TBL] [Abstract][Full Text] [Related]
15. Dramatic differences in the binding of UDP-galactose and UDP-glucose to UDP-galactose 4-epimerase from Escherichia coli.
Thoden JB; Holden HM
Biochemistry; 1998 Aug; 37(33):11469-77. PubMed ID: 9708982
[TBL] [Abstract][Full Text] [Related]
16. The metastability of human UDP-galactose 4'-epimerase (GALE) is increased by variants associated with type III galactosemia but decreased by substrate and cofactor binding.
Pey AL; PadÃn-Gonzalez E; Mesa-Torres N; Timson DJ
Arch Biochem Biophys; 2014 Nov; 562():103-14. PubMed ID: 25150110
[TBL] [Abstract][Full Text] [Related]
17. Analysis of UDP-galactose 4'-epimerase mutations associated with the intermediate form of type III galactosaemia.
Chhay JS; Vargas CA; McCorvie TJ; Fridovich-Keil JL; Timson DJ
J Inherit Metab Dis; 2008 Feb; 31(1):108-16. PubMed ID: 18188677
[TBL] [Abstract][Full Text] [Related]
18. Characterization of two mutations associated with epimerase-deficiency galactosemia, by use of a yeast expression system for human UDP-galactose-4-epimerase.
Quimby BB; Alano A; Almashanu S; DeSandro AM; Cowan TM; Fridovich-Keil JL
Am J Hum Genet; 1997 Sep; 61(3):590-8. PubMed ID: 9326324
[TBL] [Abstract][Full Text] [Related]
19. In silico prediction of the effects of mutations in the human UDP-galactose 4'-epimerase gene: towards a predictive framework for type III galactosemia.
McCorvie TJ; Timson DJ
Gene; 2013 Jul; 524(2):95-104. PubMed ID: 23644136
[TBL] [Abstract][Full Text] [Related]
20. A PCR-based method for detecting known mutations in the human UDP galactose-4'-epimerase gene associated with epimerase-deficiency galactosemia.
Henderson JM; Huguenin SM; Cowan TM; Fridovich-Keil JL
Clin Genet; 2001 Nov; 60(5):350-5. PubMed ID: 11903335
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
